Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-08-01 GOLDSMITH MARK A See Remarks Option exercise 10b5-1 +10,000 $4.09 $41K 321,885
2024-08-01 GOLDSMITH MARK A See Remarks Sale 10b5-1 −6,783 $45.60 $309K 315,102
2024-08-01 GOLDSMITH MARK A See Remarks Sale 10b5-1 −3,217 $46.48 $150K 311,885
2024-08-01 GOLDSMITH MARK A See Remarks Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 281,229
2024-07-15 Kelsey Stephen Michael See Remarks Option exercise 10b5-1 +16,667 $4.09 $68K 285,740
2024-07-15 Kelsey Stephen Michael See Remarks Sale 10b5-1 −1,100 $43.99 $48K 284,640
2024-07-15 Kelsey Stephen Michael See Remarks Sale 10b5-1 −2,128 $44.94 $96K 282,512
2024-07-15 Kelsey Stephen Michael See Remarks Sale 10b5-1 −5,760 $46.08 $265K 276,752
2024-07-15 Kelsey Stephen Michael See Remarks Sale 10b5-1 −3,800 $47.02 $179K 272,952
2024-07-15 Kelsey Stephen Michael See Remarks Sale 10b5-1 −3,879 $48.06 $186K 269,073
2024-07-15 Kelsey Stephen Michael See Remarks Option exercise · Stock Option (Right to Buy) 10b5-1 −16,667 73,332
2024-07-12 GOLDSMITH MARK A See Remarks Option exercise 10b5-1 +25,000 $4.09 $102K 336,885
2024-07-12 GOLDSMITH MARK A See Remarks Sale 10b5-1 −25,000 $45.05 $1.1M 311,885
2024-07-12 GOLDSMITH MARK A See Remarks Sale 10b5-1 −5,000 $45.01 $225K 25,424
2024-07-12 GOLDSMITH MARK A See Remarks Sale 10b5-1 −5,000 $45.01 $225K 25,424
2024-07-12 GOLDSMITH MARK A See Remarks Option exercise · Stock Option (Right to Buy) 10b5-1 −25,000 291,229
2024-07-09 Cislini Jeff General Counsel Sale 10b5-1 −2,399 $40.83 $98K 47,088
2024-07-09 Patel Sushil Director Option exercise 10b5-1 +2,155 $16.80 $36K 22,103
2024-07-09 Patel Sushil Director Sale 10b5-1 −2,155 $44.00 $95K 19,948
2024-07-09 Patel Sushil Director Option exercise · Stock Option (Right to Buy) 10b5-1 −2,155 32,490

Page 23 of 29 · 569 trades